DanielLHamilosMD
Allergy & Immunology • Mason City, IAClinical & Laboratory Immunology
Associate Professor, Medicine-Massachusetts General Hospital, Harvard Medical School
Dr. Hamilos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
250 S Crescent Dr
Mason City, IA 50401Phone+1 641-494-5380
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Allergy and Immunology, 1982 - 1983
Duke University HospitalResidency, Internal Medicine, 1979 - 1982
Northwestern University The Feinberg School of MedicineClass of 1979
Certifications & Licensure
IA State Medical License 2023 - 2027
MA State Medical License 2003 - 2024
ME State Medical License 2021 - 2023
NH State Medical License 2021 - 2023
RI State Medical License 2021 - 2022
CO State Medical License 1984 - 2007
SC State Medical License 1991 - 1992- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Diagnostic Laboratory Immunology
Awards, Honors, & Recognition
- Boston Magazine Castle Connolly, 2013
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Clinical Trials
- Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation Start of enrollment: 2008 Jan 01
Roles: Sub-Investigator, Contact
- Subcutaneous Omalizumab for Treatment of Chronic Rhinosinusitis With Nasal Polyposis Start of enrollment: 2009 Dec 01
- Pathogenesis of Chronic Sinusitis in Relationship to Tobacco Smoke Exposure Start of enrollment: 2003 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Unblocking the Treatment Stalemate in Chronic Rhinosinusitis Without Nasal Polyposis (CRSsNP).Robert M Naclerio, Daniel L Hamilos
The Journal of Allergy and Clinical Immunology. in Practice. 2024-04-01 - 413 citationsInternational consensus statement on allergy and rhinology: rhinosinusitis 2021Richard R. Orlandi, Todd T. Kingdom, Timothy L. Smith, Benjamin S. Bleier, Adam S. DeConde
International Forum of Allergy & Rhinology. 2021-03-01 - 65 citationsInterleukin-33 activates regulatory T cells to suppress innate γδ T cell responses in the lung.Lucas Faustino, Jason W. Griffith, Rod A. Rahimi, Keshav Nepal, Daniel L. Hamilos
Nature Immunology. 2020-09-28
Other
- Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitisHamilos DL
http://www.uptodate.com/contents/clinical-manifestations-pathophysiology-and-diagnosis-of-chronic-rh
UpToDate, Wolters Kluwer Health - 2013-01-31 - Management of chronic rhinosinusitisHamilos DL
http://www.uptodate.com/contents/management-of-chronic-rhinosinusitis
UpToDate, Wolters Kluwer Health - 2013-02-19
Press Mentions
Free Health & Fitness ExpoJune 17th, 2011- Addressing Childhood ObesityFebruary 12th, 2016
Grant Support
- Human Subjects CoreNational Institute Of Allergy And Infectious Diseases2011
- Core--Human SubjectsNational Heart, Lung, And Blood Institute1996–2005
- Neuropsychological Disturbance In Chronic Fatigue SyndromeNational Center For Research Resources1995
- Antigen Presentation Properties Of Mouse Dendritic CellsNational Center For Research Resources1988
- Study Of Antigen Presentation Properties Of Mouse Dendritic CellsNational Center For Research Resources1987
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
